genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
Resources
eBooks
The Year in CRISPRs
Resources
eBooks
The Year in CRISPRs
December 17, 2015
0
Share
Facebook
Twitter
Linkedin
ReddIt
Email
View eBook
Sponsored by:
Advanced Analytical
CRISPR
CRISPR-Cas9 technology
Gene editing
Genetic engineering
Genetic Engineering and Biotechnology
Genetic variants
Genetics
Mutation
Pluripotent stem cells
Regenerative engineering
Stem cell engineering
Stem cells
Also of Interest
T-Cell Therapy in Solid Tumors May Be Improved by Enzyme
Machine Learning Can Spot Tumor-Reactive TCRs, Speed Immunotherapies
Ricoh and ERS Genomics Sign CRISPR Licensing Agreement
Getting More from Microbes
Pancreatic Cancer Drug Candidate Targets Elusive, but Common, K-Ras Variant
Novel Thio-lipids Developed Capable of Reaching Eyes and Lungs in Animals
Related Media
Sickle Cell Salvation: The Victoria Gray Interview
Cas-CLOVER: An Advanced Gene Editing Technology Capable of Meeting Crop Improvement Challenges
The Possibilities of Cas-CLOVER and piggyBac
Genetics in DC: A Report from ASHG
Bioprocessing in Beantown: GEN Reports Live from Day 2 at BPI
Perfect Pitch: Genome Editing Pioneer Fyodor Urnov on Commercializing CRISPR Therapies and Epigenomic Tuning
Related Content
T-Cell Therapy in Solid Tumors May Be Improved by Enzyme
Machine Learning Can Spot Tumor-Reactive TCRs, Speed Immunotherapies
Ricoh and ERS Genomics Sign CRISPR Licensing Agreement
Getting More from Microbes
Scroll Up
MORE STORIES
Improved Nucleic Acid QC with Parallel CE
Immuno-Oncology Advances in Applied Cellular Analysis